开云app官网登录入口网页版-官方正版

#PCS#

107篇内容 | 2533人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2186006, encodeId=7e0f2186006aa, content=<a href='/topic/show?id=f02010113143' target=_blank style='color:#2F92EE;'>#食管鳞癌#</a> <a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a> <a href='/topic/show?id=0a3c1109139a' target=_blank style='color:#2F92EE;'>#磷脂酰胆碱#</a>, objectTitle=STTT：北京大学詹启敏团队揭示食管鳞癌治疗新策略, objectType=article, longId=812277, objectId=aee58122e78f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-doctor-review-PTX6YZP.jpg, objectUrl=/article/show_article.do?id=aee58122e78f, replyNumber=0, likeNumber=73, createdTime=2024-02-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=aee58122e78f, moduleTitle=STTT：北京大学詹启敏团队揭示食管鳞癌治疗新策略, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=aee58122e78f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1685657, encodeId=ba1a168565ee4, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=JCI Insight：枯草杆菌前蛋白转换酶9(PCSK9)是银屑病的新的易感基因, objectType=article, longId=735903, objectId=98d9e359036b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98d9e359036b, replyNumber=0, likeNumber=85, createdTime=2023-04-18, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98d9e359036b, moduleTitle=JCI Insight：枯草杆菌前蛋白转换酶9(PCSK9)是银屑病的新的易感基因, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=98d9e359036b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685656, encodeId=6e58168565607, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=JACC：长期抑制PCSK9和HMGCR对神经认知功能的影响, objectType=article, longId=735380, objectId=2f7ee35380bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f7ee35380bb, replyNumber=0, likeNumber=101, createdTime=2022-12-06, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f7ee35380bb, moduleTitle=JACC：长期抑制PCSK9和HMGCR对神经认知功能的影响, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=2f7ee35380bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685652, encodeId=633116856522e, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=Nutrients：在慢性他汀类药物治疗患者中，补充二十八烷醇会影响PCSK9水平并恢复其与 LDL-C的生理关系, objectType=article, longId=218804, objectId=951221880465, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=951221880465, replyNumber=0, likeNumber=92, createdTime=2022-09-21, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=951221880465, moduleTitle=Nutrients：在慢性他汀类药物治疗患者中，补充二十八烷醇会影响PCSK9水平并恢复其与 LDL-C的生理关系, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=951221880465)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685651, encodeId=f7bb1685651c2, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=JACC：高脂血症患者的福音！这些人能从强大的新型降脂药PCSK9抑制剂中获益！ , objectType=article, longId=215102, objectId=32d5215102e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32d5215102e2, replyNumber=0, likeNumber=82, createdTime=2022-03-12, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32d5215102e2, moduleTitle=JACC：高脂血症患者的福音！这些人能从强大的新型降脂药PCSK9抑制剂中获益！ , moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=32d5215102e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685655, encodeId=6e92168565516, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=Front Pharmacol：不同PCSK9抑制剂，哪个降脂力量更强？, objectType=article, longId=726544, objectId=1e53e265444e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e53e265444e, replyNumber=0, likeNumber=84, createdTime=2023-04-16, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e53e265444e, moduleTitle=Front Pharmacol：不同PCSK9抑制剂，哪个降脂力量更强？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=1e53e265444e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685654, encodeId=f9f316856546b, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=Nat Commun：多喝咖啡能续命的分子机制：咖啡因降低PCSK9，清除坏胆固醇，预防心血管疾病, objectType=article, longId=299192, objectId=011f29919231, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=011f29919231, replyNumber=0, likeNumber=80, createdTime=2022-07-31, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=011f29919231, moduleTitle=Nat Commun：多喝咖啡能续命的分子机制：咖啡因降低PCSK9，清除坏胆固醇，预防心血管疾病, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=011f29919231)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685650, encodeId=a50b168565004, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=J Clin Med：一项初步研究：PCSK9抑制剂依洛尤单抗对心血管疾病高危患者醛固酮分泌的影响, objectType=article, longId=213902, objectId=47232139022c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47232139022c, replyNumber=0, likeNumber=100, createdTime=2021-07-15, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47232139022c, moduleTitle=J Clin Med：一项初步研究：PCSK9抑制剂依洛尤单抗对心血管疾病高危患者醛固酮分泌的影响, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=47232139022c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685648, encodeId=1bf716856488b, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=防控有道，风险管理丨廉羚：降脂唯“安”：PCSK9i改善椎动脉重度狭窄, objectType=article, longId=210369, objectId=5152210369bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5152210369bb, replyNumber=0, likeNumber=100, createdTime=2021-07-13, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5152210369bb, moduleTitle=防控有道，风险管理丨廉羚：降脂唯“安”：PCSK9i改善椎动脉重度狭窄, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=5152210369bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685653, encodeId=20e11685653d5, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=AHA 2021丨MK-0616（一种口服PCSK9抑制剂）的临床安全性、药代动力学和降低低密度脂蛋白胆固醇的疗效, objectType=article, longId=220423, objectId=65e722042367, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65e722042367, replyNumber=0, likeNumber=96, createdTime=2022-05-21, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65e722042367, moduleTitle=AHA 2021丨MK-0616（一种口服PCSK9抑制剂）的临床安全性、药代动力学和降低低密度脂蛋白胆固醇的疗效, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=65e722042367)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685647, encodeId=675a168564ef6, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=JAHA：动脉粥样硬化疾病患者PCSK9抑制剂使用情况, objectType=article, longId=210568, objectId=111721056885, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=111721056885, replyNumber=0, likeNumber=66, createdTime=2022-04-09, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=111721056885, moduleTitle=JAHA：动脉粥样硬化疾病患者PCSK9抑制剂使用情况, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=111721056885)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685646, encodeId=b6b31685646c0, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=JAMA Netw Open：协作护理有助于改善青少年持续性脑震荡后综合征（PPCS）预后, objectType=article, longId=207861, objectId=f0f020e86162, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0f020e86162, replyNumber=0, likeNumber=103, createdTime=2021-12-21, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0f020e86162, moduleTitle=JAMA Netw Open：协作护理有助于改善青少年持续性脑震荡后综合征（PPCS）预后, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f0f020e86162)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685649, encodeId=be01168564906, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=防控有道，风险管理丨黄幸涛：早发冠心病患者的PCSK9i应用经验, objectType=article, longId=213650, objectId=7853213650cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7853213650cb, replyNumber=0, likeNumber=99, createdTime=2022-01-05, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7853213650cb, moduleTitle=防控有道，风险管理丨黄幸涛：早发冠心病患者的PCSK9i应用经验, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=7853213650cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685641, encodeId=7726168564165, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=专家访谈:生命至上——PCSK9抑制剂值得被更多ACS患者使用, objectType=article, longId=201145, objectId=331b20114592, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=331b20114592, replyNumber=0, likeNumber=0, createdTime=2021-03-06, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=331b20114592, moduleTitle=专家访谈:生命至上——PCSK9抑制剂值得被更多ACS患者使用, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=331b20114592)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685643, encodeId=00681685643d3, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=降脂神药！一年给药2次，药效持续17个月，诺华的siPCSK9疗法inclisiran获得欧洲CHMP的正面评价, objectType=article, longId=202221, objectId=a2c720222179, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2c720222179, replyNumber=0, likeNumber=88, createdTime=2021-02-26, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2c720222179, moduleTitle=降脂神药！一年给药2次，药效持续17个月，诺华的siPCSK9疗法inclisiran获得欧洲CHMP的正面评价, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=a2c720222179)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685642, encodeId=0b8b168564208, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=HFSA 2020：PCSK9抑制剂有效降低心脏移植后的胆固醇水平, objectType=article, longId=202055, objectId=95c92020558c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95c92020558c, replyNumber=0, likeNumber=100, createdTime=2020-11-11, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95c92020558c, moduleTitle=HFSA 2020：PCSK9抑制剂有效降低心脏移植后的胆固醇水平, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=95c92020558c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685645, encodeId=08f01685645dd, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=无论年龄和性别，诺华靶向PCSK9的siRNA疗法均可在17个月内持续有效降低LDL-C, objectType=article, longId=203468, objectId=f49f20346875, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f49f20346875, replyNumber=0, likeNumber=105, createdTime=2020-12-20, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f49f20346875, moduleTitle=无论年龄和性别，诺华靶向PCSK9的siRNA疗法均可在17个月内持续有效降低LDL-C, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f49f20346875)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685636, encodeId=3a6f16856364c, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=Circulation: PCSK9抑制剂还能抗栓！, objectType=article, longId=191429, objectId=921319142976, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=921319142976, replyNumber=0, likeNumber=96, createdTime=2020-06-27, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=921319142976, moduleTitle=Circulation: PCSK9抑制剂还能抗栓！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=921319142976)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685640, encodeId=b9b61685640e1, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=J INTERN MED：PCSK9与感染性休克患者死亡率相关, objectType=article, longId=197829, objectId=111019e82913, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=111019e82913, replyNumber=0, likeNumber=74, createdTime=2021-03-02, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=111019e82913, moduleTitle=J INTERN MED：PCSK9与感染性休克患者死亡率相关, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=111019e82913)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685637, encodeId=56f1168563e43, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=JAHA：PCSK9抑制剂对其他降脂药物的使用情况的影响, objectType=article, longId=192961, objectId=37e419296119, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37e419296119, replyNumber=0, likeNumber=97, createdTime=2020-07-09, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37e419296119, moduleTitle=JAHA：PCSK9抑制剂对其他降脂药物的使用情况的影响, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=37e419296119)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

PCS

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#食管鳞癌# #PCS# #磷脂酰胆碱#

STTT：北京大学詹启敏团队揭示食管鳞癌治疗新策略

2024-02-05发表于陕西省

Tamikia (审核中...)

前往app查看评论内容

#PCS#

JCI Insight：枯草杆菌前蛋白转换酶9(PCSK9)是银屑病的新的易感基因

2023-04-18

Tamikia (审核中...)

前往app查看评论内容

#PCS#

JACC：长期抑制PCSK9和HMGCR对神经认知功能的影响

2022-12-06

Tamikia (审核中...)

前往app查看评论内容

#PCS#

Nutrients：在慢性他汀类药物治疗患者中，补充二十八烷醇会影响PCSK9水平并恢复其与 LDL-C的生理关系

2022-09-21

Tamikia (审核中...)

前往app查看评论内容

#PCS#

JACC：高脂血症患者的福音！这些人能从强大的新型降脂药PCSK9抑制剂中获益！

2022-03-12

Tamikia (审核中...)

前往app查看评论内容

#PCS#

Front Pharmacol：不同PCSK9抑制剂，哪个降脂力量更强？

2023-04-16

Tamikia (审核中...)

前往app查看评论内容

#PCS#

Nat Commun：多喝咖啡能续命的分子机制：咖啡因降低PCSK9，清除坏胆固醇，预防心血管疾病

2022-07-31

Tamikia (审核中...)

前往app查看评论内容

#PCS#

J Clin Med：一项初步研究：PCSK9抑制剂依洛尤单抗对心血管疾病高危患者醛固酮分泌的影响

2021-07-15

Tamikia (审核中...)

前往app查看评论内容

#PCS#

防控有道，风险管理丨廉羚：降脂唯“安”：PCSK9i改善椎动脉重度狭窄

2021-07-13

Tamikia (审核中...)

前往app查看评论内容

#PCS#

AHA 2021丨MK-0616（一种口服PCSK9抑制剂）的临床安全性、药代动力学和降低低密度脂蛋白胆固醇的疗效

2022-05-21

Tamikia (审核中...)

前往app查看评论内容

#PCS#

JAHA：动脉粥样硬化疾病患者PCSK9抑制剂使用情况

2022-04-09

Tamikia (审核中...)

前往app查看评论内容

#PCS#

JAMA Netw Open：协作护理有助于改善青少年持续性脑震荡后综合征（PPCS）预后

2021-12-21

Tamikia (审核中...)

前往app查看评论内容

#PCS#

防控有道，风险管理丨黄幸涛：早发冠心病患者的PCSK9i应用经验

2022-01-05

Tamikia (审核中...)

前往app查看评论内容

#PCS#

专家访谈:生命至上——PCSK9抑制剂值得被更多ACS患者使用

2021-03-06

Tamikia (审核中...)

前往app查看评论内容

#PCS#

降脂神药！一年给药2次，药效持续17个月，诺华的siPCSK9疗法inclisiran获得欧洲CHMP的正面评价

2021-02-26

Tamikia (审核中...)

前往app查看评论内容

#PCS#

HFSA 2020：PCSK9抑制剂有效降低心脏移植后的胆固醇水平

2020-11-11

Tamikia (审核中...)

前往app查看评论内容

#PCS#

无论年龄和性别，诺华靶向PCSK9的siRNA疗法均可在17个月内持续有效降低LDL-C

2020-12-20

Tamikia (审核中...)

前往app查看评论内容

#PCS#

Circulation: PCSK9抑制剂还能抗栓！

2020-06-27

Tamikia (审核中...)

前往app查看评论内容

#PCS#

J INTERN MED：PCSK9与感染性休克患者死亡率相关

2021-03-02

Tamikia (审核中...)

前往app查看评论内容

#PCS#

JAHA：PCSK9抑制剂对其他降脂药物的使用情况的影响

2020-07-09

科室
- - 订阅+
  - 更多科室
工具
服务